GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children

Blood

Volumn 106, Issue 2, 2005, Pages 447-453

  Testi, Anna Maria ^a   Biondi, Andrea ^b   Lo Coco, Francesco ^b   Moleti, Maria Luisa ^b   Giona, Fiorina ^b   Vignetti, Marco ^b   Menna, Giuseppe ^b   Locatelli, Franco ^b   Pession, Andrea ^b   Barisone, Elena ^b   De Rossi, Giulio ^b   Diverio, Daniela ^b   Micalizzi, Concerta ^b   Aricò, Maurizio ^b   Basso, Giuseppe ^b   Foa, Robert ^b   Mandelli, Franco ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; ETOPOSIDE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RETINOIC ACID; TIOGUANINE; MESSENGER RNA; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; RNA; TUMOR PROTEIN;

ADOLESCENT; ARTICLE; BLEEDING; BONE MARROW HYPOPLASIA; BONE PAIN; BRAIN PSEUDOTUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CARDIOTOXICITY; CHEILITIS; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRY SKIN; DYSPNEA; FEMALE; FEVER; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTENSION; INFECTION; LIVER TOXICITY; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEPHROTOXICITY; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; GENETICS; INFANT; ITALY; PRESCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; FEMALE; HUMANS; IDARUBICIN; INFANT; ITALY; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; RNA, MESSENGER; RNA, NEOPLASM; TRETINOIN;

EID: 17044409146     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-05-1971     Document Type: Article

References (22)

1. Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of all trans-retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of the maintenance therapy in newly diagnosed acute promyelocytic leukemia: the European APL group. Blood. 1999;94:1192-1200.
2. Avvisati G, Petti MC, Lo Coco F, et al. Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up. Blood. 2002;100:3141-3146.
3. Cheson BO, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8:813-819.
4. Mandelli F, Diverio D, Awisati G, et al. Molecular remission in PML/RAR alpha positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood. 1997;90:1014-1021.
5. De Botton S, Dombret H, Sanz M, et al. Incidence, clinical features, and outcome of all transretinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood. 1998;8:2712-2718.
6. Avvisati G, Lo Coco F, Diverio D, et al. AIDA (all-trans retinoic acid plus idarubicin) in newly diagnosed acute promyelocytic leukemia: A GIMEMA allot study. Blood. 1996;88:1390-1398.
7. Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000;96:1247-1253.
8. Amadori S, Testi AM, Arico M, et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol. 1993;11:1046-1054.
9. Gilbert RD, Karabus CD, Mills E. Acute promyelocytic leukemia, a childhood cluster. Cancer. 1987; 59:933-935.
10. Malta-Corea A, Pacheco Espinoza C, Cantù-Rajnoldi A, et al. Childhood acute promyelocytic leukemia in Nicaragua. Ann Oncol. 1993;4:892-894.
11. Biondi A, Rovelli A, Cantù-Rajnoldi A, et al. Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). Leukemia. 1994;8:1264-1268.
12. Mann G, Reinhardt D, Ritter J, et al. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Ann Hematol. 2001;80:417-422.
13. Lanvers C, Reinhardt D, Dubbers A, et al. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia. Med Pediatr Oncol. 2003;40:293-301.
14. Hirota T, Fujimoto T, Katano L, et al. Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia: Children's Cancer and Leukemia Study Group. Rinsho Ketsueki-Jpn J Clin Hematol. 1997;38:1177-1182.
15. Smith MA, Adamson PC, Baus FM, et al. Phase I and pharmacokinetic evaluation of all-trans retinoic acid in pediatric patients with cancer. J Clin Oncol. 1992;10:1666-1673.
16. Mahmoud HH, Hurwitz CA, Roberts WM, et al. Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet. 1993;342:1394-1395.
17. De Botton S, Coiteux V, Cevret S, et al. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy. J Clin Oncol. 2004;22:1404-1412.
18. 2) in acute promyelocytic leukemia. Blood. 1993;82:3560-3563.
19. Sanz MA, Martin G, Rayon C, et al. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. Blood. 1999;9:3015-3021.
20. Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood. 2002;99:759-767.
21. Sanz MA, Martin G, Lo Coco F. Choice of chemotherapy induction, consolidation and maintenance in acute promyelocytic leukaemia. Best Pract Res Clin Haematol. 2003;16:433-451.
22. Thomas X, Le QH, Fiere D. Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia. Ann Hematol. 2002;81:504-507.